<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070679</url>
  </required_header>
  <id_info>
    <org_study_id>UMSU-Cardiology-1</org_study_id>
    <nct_id>NCT02070679</nct_id>
  </id_info>
  <brief_title>Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Urmia University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Urmia University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of vitamin E on preventing from incidence
      of contrast induced acute kidney injury (CI-AKI) in the patients who undergone coronary
      angiography.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The development of CI-AKI in group receiving vitamin E compared with placebo</measure>
    <time_frame>Within 72 hours after coronary angiography</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the serum level of Cr and the amount of eGFR</measure>
    <time_frame>Within 72 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">284</enrollment>
  <condition>Stable Angina</condition>
  <condition>Unstable Angina</condition>
  <condition>Non ST Segment Elevation Myocardial Infarction</condition>
  <condition>Post MI</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vit-E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>600 IU on 12 hours before angiography and 400 IU on 2 hours before angiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <arm_group_label>Vit-E</arm_group_label>
    <other_name>Alpha-tocopherol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. All patients whon have either stable coronary artery disease (CAD) or recent acute
             coronary disease (ACS) and are scheduled for coronary angiography.

          2. Patients who have eGFR ≤60 ml/min/1.73 m2

        Exclusion Criteria:

          1. Allergy to contrast media

          2. Cardiogenic shock

          3. Pulmonary edema

          4. Overt cardiac failure or left ventricular ejection fraction ≤ 30%

          5. Acute kidney injury

          6. The history of receiving contrast media for any medical diagnostic or therapeutic
             procedures during previous 5 days

          7. The history of dialysis

          8. Being pregnant

          9. Having recent acute myocardial infarction

         10. Taking antioxidants and nephrotoxic drugs including NSAID and ACE-I on previous 2 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seyyed-al-Shohada Heart Center, UMSU</name>
      <address>
        <city>Urmia</city>
        <state>West-Azerbaijan</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taleghani Hospital, UMSU</name>
      <address>
        <city>Urmia</city>
        <state>West-Azerbaijan</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2014</study_first_submitted>
  <study_first_submitted_qc>February 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2014</study_first_posted>
  <last_update_submitted>June 13, 2015</last_update_submitted>
  <last_update_submitted_qc>June 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Urmia University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Chancellor of research</investigator_full_name>
    <investigator_title>Mir Hossein Seyyed-Mohammadzad</investigator_title>
  </responsible_party>
  <keyword>Alpha-tocopherol</keyword>
  <keyword>Vitamin E</keyword>
  <keyword>Contrast-Induced Acute Kidney Injury</keyword>
  <keyword>Coronary angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

